Psychedelics have entered the mainstream in a big way: Investors have staked billions on potential medical treatments, scientific research has skyrocketed and public sentiment signals growing acceptance.
And yet the major sources of data on drug use have big gaps when it comes to psychedelics, making it hard to gauge exactly how consumption is changing and in what ways.
Two reports out this week offer some much-needed data points on the public’s psychoactive preferences. Together, they suggest that magic mushrooms containing the compound psilocybin are now the most popular choice. And many people are opting to microdose, consuming a fraction of the usual dose, rather than taking a full trip.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
